Alternatives
Alternatives to Vabrinty 30 mg/0.5 mL extended-release injectable suspension
1 other presentations of Leuprolide 30 mg/0.5 mL extended-release injectable suspension
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Leuprolide), strength (30 mg/0.5 mL) and dosage form (extended-release injectable suspension) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Vabrinty 30 mg/0.5 mL extended-release injectable suspensionThis pageSubcutaneous | Uronova Pharmaceuticals | US FDA | 1 syringe of 0.5 mL | Cold chain | On request | — | Available on request |
| Eligard 30 mg/0.5 mL extended-release injectable suspensionSubcutaneous | Tolmar | US FDA | 1 syringe of 0.5 mL | Cold chain | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Vabrinty 30 mg/0.5 mL extended-release injectable suspensionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.